Andrew Cuthbertson
-
FDA Green Lights CSL Behring’s Privigen for New Use
King of Prussia’s CSL Behring has received more positive news for its autoimmune and inflammatory disease disorder drug Privigen, as…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
